# FDA Inspection 728160 - Oklahoma Blood Institute  Texas Blood Institute - May 05, 2011

Source: https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-texas-blood-institute/b51f96c2-5c98-4d58-8138-74394a9b8676
Source feed: FDA_Inspections

> FDA Inspection 728160 for Oklahoma Blood Institute  Texas Blood Institute on May 05, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 728160
- Company Name: Oklahoma Blood Institute  Texas Blood Institute
- Inspection Date: 2011-05-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1168570 - 2022-04-22](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-texas-blood-institute/3354988d-23d3-4d5b-87bc-b4eff1954129)
- [FDA Inspection 1168570 - 2022-04-22](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-texas-blood-institute/d68fcfce-8881-43c3-8077-d6b583357a49)
- [FDA Inspection 1027102 - 2017-09-22](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-texas-blood-institute/14277fe9-922f-4e20-9058-f6b9f9da7afc)
- [FDA Inspection 858221 - 2013-12-04](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-texas-blood-institute/c4ba2045-ba44-43ff-b62d-8058dfb0f124)
- [FDA Inspection 604725 - 2009-08-12](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-texas-blood-institute/b0d1ce9f-d2d8-4fb1-9815-c5d066ccceb8)

Company: https://www.keypedia.com/companies/oklahoma-blood-institute-texas-blood-institute/bbaf5735-cef1-4dce-ad45-4d2c177e274c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d